Skip to main content

Journal of Cancer Education

Ausgabe 4/2019

Inhalt (31 Artikel)

EDITORIAL

An Opportunity to Share

Maria C. Bishop

Mentorship in Medicine and Other Health Professions

Nayanee Henry-Noel, Maria Bishop, Clement K. Gwede, Ekaterina Petkova, Ewa Szumacher

A Framework for Culturally Relevant Online Learning: Lessons from Alaska’s Tribal Health Workers

Katie Cueva, Melany Cueva, Laura Revels, Anne P. Lanier, Mark Dignan, K. Viswanath, Teresa T. Fung, Alan C. Geller

Supporting Latina Breast Health with Community-based Navigation

Jennifer D. Keith, Nichole E. Kang, MatheRose Bodden, Christina Miller, Vanesa Karamanian, Tinesha Banks

Biospecimen Education Among Pacific Islanders in Southern California

Nasya S. Tan, Harold Custodio, Mandy LaBreche, Cleo Carlos Fex, Vanessa Tui’one May, Jane Ka’ala Pang, Victor Kaiwi Pang, Lola Sablan-Santos, Tupou Toilolo, Alisi Tulua, Dorothy Schmidt Vaivao, Melanie Sabado-Liwag, James Russell Pike, Bin Xie, Patchareeya P. Kwan, Paula Healani Palmer, Sora Park Tanjasiri

Primary Care Providers’ Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening

Sun Hee Rim, Ingrid J. Hall, Greta M. Massetti, Cheryll C. Thomas, Jun Li, Lisa C. Richardson

Pain Knowledge and Attitudes Among Nurses in Cancer Care in Norway

Inger Utne, Milada Cvancarova Småstuen, Ulla Nyblin

Awareness of HPV and Cervical Cancer Prevention Among University Health Sciences Students in Cyprus

Paraskevi A. Farazi, Mohammad Siahpush, Tzeyu L. Michaud, Jungyoon Kim, Chenai Muchena

Assessment of Radiology Training During Radiation Oncology Residency

Shanna A. Matalon, Stephanie A. Howard, Matthew J. Abrams

Computer-Based Readability Testing of Information Booklets for German Cancer Patients

Christian Keinki, Richard Zowalla, Monika Pobiruchin, Jutta Huebner, Martin Wiesner

Evaluating the Training of Chinese-Speaking Community Health Workers to Implement a Small-Group Intervention Promoting Mammography

Jiayan Gu, Annette E. Maxwell, Grace X. Ma, Xiaokun Qian, Yin Tan, Hsing-Chuan Hsieh, Shin-Ping Tu, Judy Huei-yu Wang

Focus Groups and In-depth Interviews to Guide the Development of Lung Cancer Screening Informational Materials

Anushree Sharma, Richard O’Connor, Paula Celestino, Samantha Killion, Laurie Griswold-Krupski, Maansi Bansal-Travers

The American Society of Hematology (ASH) Medical Educators Institute: a Pilot Faculty Development Project for Hematology Educators

Jennifer C. Kesselheim, Charles P. Clayton, Josel Fritz, Roy E. Smith, Scott D. Gitlin, Erin Reid, Kenneth S. Zuckerman, Marc J. Kahn

The Influence of Patient Identification and Narrative Transportation on Intentions to Participate in Cancer Research

Jordan M. Neil, Aisling Gough, Frank Kee, Thomas J. George Jr, Jeffrey Pufahl, Janice L. Krieger

Attitude Towards End of Life Communication of Austrian Medical Students

Tamara Rumpold, Carola Lütgendorf-Caucig, Henriette Löffler-Stastka, Sophie Roider-Schur, Richard Pötter, Kathrin Kirchheiner

Development of a Professional Certification in Cancer Patient Education

Janet Papadakos, Anna D’souza, Adeline Masse, Susan Boyko, Susan Clarke, Meredith Giuliani, Keira MacKinnon, Sarah McBain, Meg McCallum, Jan MacVinnie, Tina Papadakos

Quality of Life in Patients with Non-melanoma Skin Cancer: Implications for Healthcare Education Services and Supports

Robabeh Abedini, Maryam Nasimi, Pedram Noormohammad Pour, Atie Moghtadaie, Hamid Reza Tohidinik

Quality, Readability, and Understandability of German Booklets Addressing Melanoma Patients

Julia Brütting, Lydia Reinhardt, Maike Bergmann, Dirk Schadendorf, Christiane Weber, Wolfgang Tilgen, Carola Berking, Friedegund Meier

Student Perspectives on the Impact of an Undergraduate Work-Integrated Learning Program on Admission and Transition to Medical School

Rachel McDonald, Adam Bobrowski, Leah Drost, Leigha Rowbottom, Judene Pretti, Hany Soliman, Stephanie Chan, Edward Chow

Patient-Focused Online Resources for Melanoma: Highly Variable Content and Quality

Eman A. Alshaikh, Abdulaziz F. Almedimigh, Abdulmajeed M. Alruwaili, Abdullah H. Almajnoni, Ali Alhajiahmed, Thamer S. Almalki, Sukayna Z. Alfaraj, Jesse M. Pines

Human Papillomavirus-Related Oral Cancer: Knowledge and Awareness Among Spanish Dental Students

Alejandro Ismael Lorenzo-Pouso, Pilar Gándara-Vila, Cristina Banga, Mercedes Gallas, Mario Pérez-Sayáns, Abel García, Ellen M. Daley, Iria Gasamáns

How Is Health Literacy Related to Pap Testing Among US Women?

Erika L. Thompson, Christopher W. Wheldon, Cheryl A. Vamos, Stacey B. Griner, Ellen M. Daley

Evaluating Adaptation of a Cancer Clinical Trial Decision Aid for Rural Cancer Patients: A Mixed-Methods Approach

Swati Pathak, Nerissa George, Denise Monti, Kathy Robinson, Mary C. Politi

Social Media as a Tool to Promote Health Awareness: Results from an Online Cervical Cancer Prevention Study

Helena C. Lyson, Gem M. Le, Jingwen Zhang, Natalie Rivadeneira, Courtney Lyles, Kate Radcliffe, Rena J. Pasick, George Sawaya, Urmimala Sarkar, Damon Centola

French Therapeutic Education Programme Aimed at Improving the Quality of Life of Laryngectomised Patients and their Close Relations: the Three Stages (Observational and Interventional Randomised) of the Study “PETAL”

Natacha Heutte, Moumainn Abouzayd, Laetitia Plisson, Mélanie Trocmé, Mélanie Seillier, Véronique Christophe, Lydia Guittet, Guillaume Grandazzi, Emmanuel Babin

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.